Nanite
Developer of AI-driven non-viral gene delivery systems
Funding snapshot
About
Developer of AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to create programmable and effective delivery vehicles for a wide range of genetic medicines.
Latest news
No articles yet.
Similar startups
PayFlow
Embedded payments infrastructure for Southeast Asian marketplaces and platforms.
GreenGrid
Software for planning and operating distributed battery storage across Europe.
Immuneel
Developer of T-cell therapies for the treatment of cancer
ImmunoACT
Developer of cell and gene therapies for cancer treatment